Diabetic patients with time in range above 70% achieved 88.54% primary patency at 12 months after endovascular therapy for femoropopliteal artery occlusion.
Time in range glucose targets above 70% improve 12-month primary patency rates after endovascular therapy for diabetic femoropopliteal artery occlusion.
Researchers evaluated 162 patients with diabetic femoropopliteal artery occlusion in a prospective cohort study. Investigators split participants into two groups based on seven-point glucose profiles recorded within seven days.
The study compared patients with a time in range below 70% against those with a time in range above 70%. These groups showed distinct differences in glycemic control metrics and subsequent vascular healing.
Patients with a time in range below 70% recorded an average time in range value of 58.84 ± 7.72%. Participants with a time in range above 70% achieved an average value of 78.34 ± 6.13%.
The primary patency rate at 12 months reached 71.67% in the lower time in range group. In contrast, the group with a time in range above 70% attained a primary patency rate of 88.54%.
Restenosis rates climbed to 28.33% for patients with lower glycemic control. Patients in the higher time in range group experienced a restenosis rate of 11.46%.
| Clinical Parameter | TIR Below 70% Group | TIR Above 70% Group |
|---|---|---|
| Time in Range Value | 58.84 ± 7.72% | 78.34 ± 6.13% |
| 12-Month Primary Patency | 71.67% | 88.54% |
| Restenosis Rate | 28.33% | 11.46% |
| Target Lesion Revascularization | 23.33% | 8.33% |
Clinically-driven target lesion revascularization occurred in 23.33% of patients with a time in range below 70%. Only 8.33% of patients in the higher time in range group required this intervention.
Severe calcification carried a hazard ratio of 4.08 with a 95% confidence interval ranging from 1.86 to 8.97. Time in range registered an independent hazard ratio of 0.025 with a 95% confidence interval from 0.001 to 0.70.
These statistical evaluations confirmed both severe calcification and time in range as independent risk factors for restenosis after endovascular therapy.
Worth a look